Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Researchers uncover new way to enhance function of immune cells to combat multiple myeloma

Researchers uncover new way to enhance function of immune cells to combat multiple myeloma

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Investigational compound inhibits cancer-specific mutations in mice

Investigational compound inhibits cancer-specific mutations in mice

Study shows how different genetic mutations cause acute myeloid leukemia

Study shows how different genetic mutations cause acute myeloid leukemia

Seattle Children’s opens first clinical trial to study IBD and GVHD in pediatric patients

Seattle Children’s opens first clinical trial to study IBD and GVHD in pediatric patients

Researchers show how DPF2 protein controls blood cell production in leukemia

Researchers show how DPF2 protein controls blood cell production in leukemia

Cancer drug may help treat food allergies

Cancer drug may help treat food allergies

New findings shed light on factors that impact hospice referrals for patients with blood cancers

New findings shed light on factors that impact hospice referrals for patients with blood cancers

Researchers discover innovative way to produce hematopoietic stem cells

Researchers discover innovative way to produce hematopoietic stem cells

Researchers identify new drug target for two common types of myeloid leukemia

Researchers identify new drug target for two common types of myeloid leukemia

Children surviving chronic health conditions may suffer from brain function issues

Children surviving chronic health conditions may suffer from brain function issues

UT Health scientists discover epigenetic changes that contribute to AML

UT Health scientists discover epigenetic changes that contribute to AML

New trial aims to prolong remission for pediatric leukemia patients treated with T-cell immunotherapy

New trial aims to prolong remission for pediatric leukemia patients treated with T-cell immunotherapy

WHO to launch pilot project for prequalifying biosimilar cancer medicines

WHO to launch pilot project for prequalifying biosimilar cancer medicines

Vitamin A deficiency leads to loss of blood stem cells

Vitamin A deficiency leads to loss of blood stem cells

FDA approves new AML drug after clinical testing at Dana-Farber

FDA approves new AML drug after clinical testing at Dana-Farber

Molecular mechanism reprograms tumor cells to drive treatment resistance in advanced prostate cancer

Molecular mechanism reprograms tumor cells to drive treatment resistance in advanced prostate cancer

Researchers identify key player in initiation and progression of melanoma

Researchers identify key player in initiation and progression of melanoma

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Invivoscribe receives FDA approval for the LeukoStrat CDx FLT3 mutation assay companion diagnostic test for the selection of patients for Rydapt

Invivoscribe receives FDA approval for the LeukoStrat CDx FLT3 mutation assay companion diagnostic test for the selection of patients for Rydapt

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.